CA
CanSino Biologics Inc.
CASBF · OTC
$3.90 +32.20% (+$0.95)
Market Cap ¥6.92B
P/E Ratio 170.18x
Div. Yield -
ROE 0.82%
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Moderate
6/9Valuation
20 /100
Expensive EV/EBITDA 87.49x
P/S 5.64x
P/B 1.39x
Growth
16 /100
Declining Book val. growth 9.78%
Rev. growth 0.03%
FCF growth N/A
Profitability
25 /100
Weak Net margin 3.31%
Op. margin 4.62%
FCF margin 10.46%
Quality
4 /100
Poor ROE 0.82%
ROA 0.59%
Asset turnover 0.18x
Debt
80 /100
Low Current ratio 4.39x
Int. coverage -0.66x
Net debt/EBITDA -2.51x
Stability
21 /100
Unstable Rev. volatility 102.95%
EPS volatility 90.25%
Profitable years 1
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CASBF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Xue Feng Yu
Employees
1,134
Headquarters
Tianjin
Prihajajoči dogodki
02 NOV.
Earnings
Upcoming earnings report
30 MAR.
Earnings
Upcoming earnings report